Caspofungin acetate
Products billed under this code include Cancidas, Caspofungin, Caspofungin Acetate.
Payment limit per 5 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Cancidas, Caspofungin, Caspofungin Acetate.
Payment limit per 5 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Cancidas | Merck Sharp & Dohme LLC | 00006-3822-10 | 10 | $24.63 |
| Cancidas | Merck Sharp & Dohme LLC | 00006-3823-10 | 14 | $34.482 |
| Caspofungin | Fosun Pharma USA Inc. | 72266-0106-01 | 10 | $24.63 |
| Caspofungin | Fosun Pharma USA Inc. | 72266-0107-01 | 14 | $34.482 |
| Caspofungin Acetate | Sandoz Inc. | 00781-3421-94 | 10 | $24.63 |
| Caspofungin Acetate | Sandoz Inc. | 00781-3423-94 | 14 | $34.482 |
| Caspofungin Acetate | Sagent Pharmaceuticals | 25021-0194-10 | 10 | $24.63 |
| Caspofungin Acetate | Sagent Pharmaceuticals | 25021-0195-10 | 14 | $34.482 |
| Caspofungin Acetate | Areva Pharmaceuticals | 59923-0613-70 | 14 | $34.482 |
| Caspofungin Acetate | Areva Pharmaceuticals | 59923-0614-50 | 10 | $24.63 |
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Caspofungin Acetate | FreseniUS Kabi USA, LLC | 63323-0356-10 | 100 | $246.30 |
| Caspofungin Acetate | FreseniUS Kabi USA, LLC | 63323-0358-10 | 140 | $344.82 |
| Caspofungin Acetate | Athenex Pharmaceutical Division, LLC | 70860-0106-10 | 10 | $24.63 |
| Caspofungin Acetate | Athenex Pharmaceutical Division, LLC | 70860-0107-10 | 14 | $34.482 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $2.463 | −$0.416 | 5 MG | Caspofungin acetate | v1, posted September 17, 2026 |
| 3Q26 | $2.879 | −$0.696 | 5 MG | Caspofungin acetate | v1, posted September 15, 2026 |
| 2Q26 | $3.575 | −$0.243 | 5 MG | Caspofungin acetate | v1, posted September 15, 2026 |
| 1Q26 | $3.818 | +$0.277 | 5 MG | Caspofungin acetate | v1, posted September 15, 2026 |
| 4Q25 | $3.541 | +$1.275 | 5 MG | Caspofungin acetate | v1, posted September 8, 2026 |
| 3Q25 | $2.266 | −$1.07 | 5 MG | Caspofungin acetate | v1, posted March 10, 2026 |
| 2Q25 | $3.336 | −$1.719 | 5 MG | Caspofungin acetate | v1, posted March 10, 2026 |
| 1Q25 | $5.055 | −$1.265 | 5 MG | Caspofungin acetate | v1, posted December 19, 2025 |
| 4Q24 | $6.32 | −$0.395 | 5 MG | Caspofungin acetate | v1, posted June 11, 2025 |
| 3Q24 | $6.715 | +$0.086 | 5 MG | Caspofungin acetate | v1, posted June 11, 2025 |
| 2Q24 | $6.629 | +$1.202 | 5 MG | Caspofungin acetate | v1, posted March 11, 2025 |
| 1Q24 | $5.427 | −$0.073 | 5 MG | Caspofungin acetate | v1, posted December 19, 2024 |
| 4Q23 | $5.50 | −$3.121 | 5 MG | Caspofungin acetate | v1, posted October 10, 2024 |
| 3Q23 | $8.621 | +$3.734 | 5 MG | Caspofungin acetate | v1, posted June 5, 2024 |
| 2Q23 | $4.887 | −$0.73 | 5 MG | Caspofungin acetate | v1, posted February 23, 2024 |
| 1Q23 | $5.617 | −$2.802 | 5 MG | Caspofungin acetate | v1, posted December 6, 2023 |
| 4Q22 | $8.419 | +$2.938 | 5 MG | Caspofungin acetate | v1, posted June 22, 2023 |
| 3Q22 | $5.481 | +$0.154 | 5 MG | Caspofungin acetate | v1, posted June 9, 2023 |
| 2Q22 | $5.327 | −$1.242 | 5 MG | Caspofungin acetate | v1, posted December 14, 2022 |
| 1Q22 | $6.569 | +$0.319 | 5 MG | Caspofungin acetate | v1, posted June 8, 2022 |
| 4Q21 | $6.25 | −$0.739 | 5 MG | Caspofungin acetate | v1, posted June 2, 2022 |
| 3Q21 | $6.989 | −$1.811 | 5 MG | Caspofungin acetate | v1, posted June 2, 2022 |
| 2Q21 | $8.80 | +$2.153 | 5 MG | Caspofungin acetate | v1, posted March 1, 2022 |
| 1Q21 | $6.647 | – | 5 MG | Caspofungin acetate | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.